Genmab A (GMAB) Exchange Rate Effect (2023 - 2026)
Genmab A (GMAB) posted Exchange Rate Effect of -$11.0 million for Q1 2026, down 257.14% on a QoQ basis from $7.0 million in Q3 2025, and down 237.5% year-over-year from $8.0 million in Q1 2025.
Genmab A (GMAB) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Genmab A's Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$11.0 million for Q1 2026.
- Quarterly Exchange Rate Effect fell 237.5% year-over-year to -$11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (down 73.08% YoY) and the FY2025 annual result came in at $3.0 million, down 95.24% from the prior year.
- Exchange Rate Effect was -$11.0 million for Q1 2026 at Genmab A, down from $7.0 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $34.0 million in Q3 2024 and bottomed at -$15.0 million in Q2 2024.
- A 4-year average of $1.6 million and a median of $1.0 million in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect surged 900.0% — and 2026, when it slumped 237.5%.
- Genmab A's Exchange Rate Effect stood at -$12.0 million in 2023, then soared by 383.33% to $34.0 million in 2024, then sank by 79.41% to $7.0 million in 2025, then slumped by 257.14% to -$11.0 million in 2026.
- Business Quant data shows GMAB's Exchange Rate Effect at -$11.0 million in Q1 2026, $7.0 million in Q3 2025, and $3.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | -11.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Sep 30, 2024 | 34.00 Mn |
| Sep 30, 2024 | 34.00 Mn |
| Jun 30, 2024 | -15.00 Mn |
| Jun 30, 2024 | -15.00 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Dec 31, 2023 | -12.00 Mn |
| Dec 31, 2023 | -12.00 Mn |